• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
    • FSAPAC Donors for 2025
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

2023 FSA Podium and Poster Abstracts

2023 FSA Podium and Poster Abstracts

P050: UNRAVELING THE MYSTERY: A CASE OF BILATERAL PULMONARY EMBOLISM LINKED TO ANABOLIC STEROID USE AND ELEVATED HOMOCYSTEINE
Dagoberto J Morales, MD1; William A Perez, MD1; Guillermo Loyola, OMSIII2; Jose U Sanchez, MD1; 1Palmetto General Hospital; 2Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Introduction: Anabolic steroid use has been linked to several health complications, including an increased risk of thromboembolic events. Hyperhomocysteinemia, a metabolic disorder is also a known risk factor for thrombotic events. We present a case in which both are present.

Case description: A 28-year-old male with no significant past medical history presented to our Emergency Department (ED) with a chief complaint of right knee pain after working out. Right knee X-ray in the ED came back negative with no acute findings. Patient underwent lower extremity ultrasound, notable for deep vein thrombosis (DVT) in the right popliteal and posterior tibial veins. No family history of thrombus formation. Subsequently, a Computed Tomography Angiography (CTA) was notable for bilateral submassive pulmonary embolism, and no right heart strain noted. The patient was immediately started on heparin. Patient reported history of anabolic steroid use. Homocysteine level in the blood was also ordered which came back elevated at 18.5 umol/L (normal: <13 umol/L). The patient was discharged on novel oral anticoagulants for 6 months.

Discussion: Further research is needed to fully understand the relationship between anabolic steroid use, hyperhomocysteinemia, and thromboembolic events and to develop effective strategies for managing these risks.

References

  • Graham MR, Grace FM, Boobier W, Hullin D, Kicman A, Cowan D, Davies B, Baker JS. Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse. Br J Sports Med. 2006 Jul;40(7):644-8. doi: 10.1136/bjsm.2005.025668. Epub 2006 Feb 17. PMID: 16488899; PMCID: PMC2564318.
  • Kovalenko O, Kassem AN, Jenkins M. Hyperhomocysteinemia and Pulmonary Embolism in a Young Male. Cureus. 2020 Apr 24;12(4):e7818. doi: 10.7759/cureus.7818. PMID: 32467793; PMCID: PMC7249768.
  • Liljeqvist, Sissela, et al. “Pulmonary Embolism Associated with the Use of Anabolic Steroids.” European Journal of Internal Medicine, vol. 19, no. 3, 2008, pp. 214–215., https://doi.org/10.1016/j.ejim.2007.03.016.

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved